A new screening tool can identify the hidden driver of a silent killer through standard blood work, bypassing the need to ask ...

NorthSea Therapeutics B.V. ("NorthSea" or the "Company"), a private, late-stage clinical biotechnology company leveraging its proprietary structurally engineered fatty acids (SEFAs) platform to ...

Orziloben granted Orphan Drug Designation in the U.S. and European Union Company expects to report topline results from Phase 2 study in Q3 2026 NorthSea Therapeutics B.V. ("NorthSea" or the "Company" ...

First of two Pivotal Efficacy Studies support future sNDA submission for Treatment of Pulmonary AnthraxOral NUZYRA Tablets Produced in the U.S. as a Result of the Company's Onshoring Initiative were ...

Scientists identify a DNA methylation alcohol biomarker that tracks exposure and aging signals, offering new insight into how drinking patterns may shape long-term health. Study: Alcohol Consumption ...

Tech tycoons, podcast bros and Hollywood stars are all piling money into full-body scans, which deploy AI in the hope of catching everything from high cholesterol to cancer. Is this the first step to ...

A new study suggests that even modest amounts of this carbonated beverage may be associated with higher rates of metabolic fatty liver disease. A new study, published in the Annals of Hepatology, ...

Japan now offers ELEVIDYS gene therapy to children with Duchenne muscular dystrophy aged 3 years to less than 8 years- Company is eligible to receive a $40 million milestone payment upon first ...

-- First of two Pivotal Efficacy Studies support future sNDA submission for Treatment of Pulmonary Anthrax -- Oral NUZYRA Tablets Produced in the U.S. as a Result of the Company's Onshoring Initiative ...

Rheumatologist Dr Thomas Batty and haematologist Dr Emma Conway O'Brien describe a rational approach to investigating multifocal pain ...